How to Spot Fake GLP-1 Pens in India | MetaGO

How to Spot a Counterfeit GLP-1 Pen in India

Table of Contents

Quick Answer
A genuine Ozempic or Mounjaro pen in India comes from a licensed chemist, with a bill, in a sealed carton whose batch number and expiry match the pen label exactly. Warning signs include spelling errors, a label that peels or sits crooked, a cap or dose window that differs from the leaflet, and a pen delivered without cold packing. A real batch number does not prove a pen is real. Forgers copy genuine numbers, so confirm the batch with the manufacturer. Fake pens seized abroad have contained insulin, which can push blood sugar dangerously low. Report a suspected fake to your state drug controller and CDSCO. Report any reaction on the PvPI helpline.

Why Counterfeit GLP-1s Are a Growing Problem

Forgers follow demand, and India’s demand for GLP-1 medicines grew faster than almost anyone expected. Within a single year the country went from having no approved weight-loss injection to having several.

Mounjaro launched in March 2025 and became India’s top-selling medicine by value within months. Wegovy arrived in June 2025, and Ozempic in December. Then, on 20 March 2026, the patent on the medicine inside Ozempic and Wegovy expired in India, and dozens of new brands reached chemist shelves within days.

For a buyer, that meant a shelf full of unfamiliar names. For a counterfeiter, that confusion is cover.

The first major Indian seizure followed within weeks. In April 2026, Haryana’s Food and Drug Control Administration recovered more than 260 suspected fake Mounjaro pens from a vehicle on the outskirts of Delhi. 

Officials said the pens were made at a private property by a person with no pharmaceutical license, sold through an online wholesale marketplace, and kept without any temperature control. Their labels gave them away: the font sizes and small print did not match the original.

The regulator has moved too. In March 2026, the Central Drugs Standard Control Organisation (CDSCO) inspected 49 points in the supply chain, from online pharmacies to wellness clinics. In May it asked every state drug controller to make sure these medicines move only through authorised channels.

None of this is unique to India. The WHO Medical Product Alert N°2/2024 confirmed three falsified Ozempic batches found in Brazil, the UK and the US, after its global surveillance system had logged reports of fake versions from every region since 2022. 

And the broader backdrop is sobering: a meta-analysis by Ozawa and colleagues in JAMA Network Open found that roughly one in eight essential medicines tested in low- and middle-income countries was substandard or falsified.

Visual Signs of a Fake Pen

No single check settles the question. A fake usually fails several small ones at once, so look at the carton, the pen, and the seller together.

The reference to trust is the leaflet inside a pack you know is genuine, along with the product pictures on the manufacturer’s official Indian website. Compare against those, not against photos sent by a seller.

Packaging and labels

Indian law has already written you a checklist. Under the Drugs Rules, a prescription medicine’s label must show the batch number, the manufacturing and expiry dates, the manufacturer’s name and address, and the Rx symbol with a warning that it can be sold only on a doctor’s prescription.

An imported medicine must also print its import license number (marked “Import Lic. No.”) and the name and address of the Indian importer. CDSCO allows stickers or overprinting on imported packs only by licensed importers, so a carton printed entirely in a foreign language with no Indian details was never meant for an Indian chemist.

CheckWhat a genuine pack showsWarning sign
Batch and expiryPrinted identically on the carton and the penA mismatch, smudged print, or a sticker covering the original
Importer detailsImport license number and the Indian importer’s nameMissing, or a foreign-language pack with no Indian details
Print qualitySharp text and consistent fontsUneven font sizes, spelling errors, blurred logos
SealIntact and untouchedRe-glued flaps, a torn or missing seal
LeafletPresent and matching the pen insideMissing, photocopied, or written for a different product

Spelling deserves a second look. One of the batches in the WHO alert carried spelling mistakes on the front of the box, the kind of error a real manufacturer’s print run almost never lets through.

Pen body, label, and dose window

The pen is harder to fake than the box, and regulators abroad have documented exactly where forgers slip.

Australia’s Therapeutic Goods Administration (TGA) alert described two pens labeled Ozempic that were relabeled insulin pens. The cap was a different color, the dose barrel sat in a different place, and the label did not stick properly to the pen. 

Germany’s regulator described a fake whose safety window was transparent instead of grey, and WHO noted a dose scale that slid out of the pen body while the dose was being set.

CheckWhat to look for
LabelLies flat, sits straight, and repeats the carton’s batch, expiry, and strength word for word
Cap and body colorMatch the leaflet pictures exactly; a different shade is a warning
Dose window and dialSame position and markings as the leaflet; nothing loose or protruding
StrengthThe batch belongs to the strength printed on the pen, not a different one
Device typeMatches what your doctor prescribed and explained

Strength matters more than most people realize. In February 2026, the UK regulator found falsified Mounjaro 15 mg pens carrying a batch number that genuinely belonged to the 7.5 mg strength. The number was real; the pen was not, and its mechanism was faulty.

Know the device you were prescribed. The Mounjaro KwikPen sold in India is a multi-dose pen holding four weekly doses, and it is discarded after the fourth dose or 30 days after first use. If what you receive looks different from what your doctor described, ask before you inject.

Price and seller red flags

Where a pen comes from tells you more than how it looks. A good copy can fool the eye; a bad seller is much harder to hide.

Red flagWhy it matters
No prescription asked forLicensed chemists must sell these medicines only on a doctor’s prescription
Sold over Instagram, WhatsApp, or a wholesale marketplace to an individualOutside the licensed chain that regulators can trace
“Imported stock” or “direct from abroad” claimsGenuine imports reach you through a licensed importer, with Indian details on the pack
A price far below every licensed chemistThe Haryana pens were sold at a discount to the real thing
No bill, or a bill without the batch numberLeaves you nothing to verify or report
Courier delivery with no ice packUnopened pens must stay at 2 to 8°C

Heat is the quiet risk even when the pen is genuine. A parked delivery van on a Mumbai afternoon in May can run well past the 30°C ceiling that an in-use pen tolerates, and an unopened pen should never leave the fridge in the first place.

How to Verify a Batch Number

A batch number proves only that someone printed it. The manufacturer is the one party that can tell you whether it belongs to a real production run.

The WHO alert shows why. Of the three falsified Ozempic batches, one number was simply unknown, one pairing of batch and serial number did not exist in the manufacturer’s records, and one batch number was completely genuine, printed on a fake pen. Copying a real number costs a forger nothing.

StepWhat to do
1Write down the batch number, expiry date, and strength from both the carton and the pen. They must match.
2Ask your chemist for a bill that shows the batch number, and check it against the pack.
3Contact the manufacturer using the details in the leaflet or on its official Indian website. Share the batch, strength, expiry, and where you bought it.
4Check CDSCO’s monthly drug alerts, which list batches declared spurious or not of standard quality.
5Keep the pen, carton, and bill until you hear back. Do not inject while you wait.

Use only contact details printed in the pack or published on the official site. A phone number from a search ad or a seller’s message can lead straight back to the people who sold the fake.

What Counterfeit Pens Have Contained

The most dangerous fakes do not contain a weaker GLP-1. They contain a different medicine altogether.

The UK’s MHRA Drug Safety Update (November 2023) confirmed five cases in which pens sold as Ozempic or Saxenda were insulin pens in disguise. Some of the people who used them were taken to hospital and needed urgent care.

Laboratory testing in Australia went further and named the drug: a fast-acting insulin (insulin glulisine). Austria’s regulator reported low blood sugar and seizures in users of fake pens.

Insulin pens look broadly similar to GLP-1 pens, which is likely why forgers relabel them. Other fakes have held unknown or substituted ingredients, the wrong strength, or nothing active at all. The Haryana pens are still being tested; officials said the raw peptides had been bought from overseas online vendors.

Health Risks of Fake Pens

The outcome ranges from nothing happening to a medical emergency, and the person injecting has no way of knowing which in advance.

What was in the penWhat it can do
InsulinA sudden fall in blood sugar (hypoglycemia): shaking, sweating, confusion, a racing heart, blurred vision, seizures
Contaminated or unsterile liquidInfection or an abscess at the injection site
The wrong strengthSevere nausea, vomiting, and dehydration, or no effect
Nothing activeNo effect at all, and for people with diabetes, blood sugar left untreated

If you feel shaky or sweaty after an injection, eat or drink something sugary straight away, such as a glass of fruit juice, and get emergency care. Take the pen with you so doctors know what you injected.

There is a second, slower risk. A pen bought without a prescription comes without the doctor who would adjust your dose, watch for side effects, and check whether the medicine suits you at all.

What to Do If You Suspect a Fake

Stop first. Do not inject a pen you doubt, even to “test” it.

StepAction
1If you have already injected and feel unwell, get emergency care and take the pen with you.
2Keep everything: pen, carton, leaflet, bill, and screenshots of the seller’s listing and chats. Regulators may need the pen for testing.
3Call the doctor who prescribed it and tell them what happened.
4Contact the manufacturer with the batch details.
5Report it to the authorities listed below.

How to Report It in India (CDSCO, state drug controller)

India separates two kinds of reports: one about the product, and one about what it did to you. File both if they apply.

What happenedWho to tellHow
You suspect a fake penYour state drug controller (the state Food and Drugs Administration or Drugs Control Department)Contact the nearest office; state inspectors can seize stock and send samples for testing
You suspect a fake penCDSCO, the national regulatorThrough the website, CDSCO coordinates with states and publishes spurious-drug alerts
You had a side effect or reactionPharmacovigilance Programme of India (PvPI)Toll-free number, the ADRPvPI mobile app, or the QR code at your chemist
It was sold onlineThe platform that listed itReport the listing so it is taken down

Two details are worth knowing. Since November 2025, CDSCO has directed every retail and wholesale pharmacy to display the PvPI QR code and helpline, so the reporting tool should be on the wall at your chemist. 

CDSCO also runs a whistleblower scheme that rewards people whose information helps regulators act against spurious drugs.

Buying Safely

The safest pen is the unremarkable one: prescribed by a doctor, bought from a licensed chemist, handed over cold, with a bill.

The licensed system is far cleaner than its reputation. India’s National Drug Survey 2014-16 tested more than 47,000 medicine samples and found spurious drugs in 0.0245% of them, about one in 4,000. The risk concentrates outside that system, among sellers who skip the prescription.

Before you buyAt the counter
Get a prescription from a registered doctorCheck the seal, batch, and expiry before you leave
Use a chemist that displays its drug licenseMake sure the pen comes from the fridge
If ordering online, use a pharmacy that asks for your prescription and names its pharmacistAsk for a bill showing the batch number

An unfamiliar brand name is not, by itself, a fake. Many legitimate Indian versions launched after March 2026. Check the manufacturer’s name and license details on the carton, and ask your doctor before switching brands.

These are prescription medicines, and CDSCO is clear that they should be prescribed only by registered medical practitioners for approved uses. A doctor-guided plan is what keeps the dose, the side effects, and the source in check.

Conclusion
Counterfeit GLP-1 pens are a real and growing problem in India, and some fakes have held insulin. Buy only on prescription from a licensed chemist, match the batch on the carton, pen, and bill, confirm it with the manufacturer, and report anything suspicious to your state drug controller, CDSCO, or PvPI.

Frequently Asked Questions

1. How do I know if my GLP-1 pen is genuine?

Buy it on prescription from a licensed chemist and ask for a bill with the batch number. Check that the expiry and strength on the carton match the pen and the bill. Check if the pen matches the leaflet pictures. Confirm the batch with the manufacturer using contact details from the leaflet or its official Indian website.

2. What are the visual signs of a counterfeit pen?

Look for spelling errors, uneven fonts, a crooked or peeling label, a broken or re-glued seal, and a missing Indian importer’s name on an imported pack. On the pen, a cap color, dose window, or dial position that differs from the leaflet is a warning. A pen delivered warm, without cold packing, is another.

3. How do I verify a batch number with the manufacturer?

Note the batch number, expiry, and strength from both the carton and the pen. Contact the manufacturer through the details printed in the leaflet or on its official Indian website, and share where you bought the pen. Remember that a genuine-looking batch number can be copied, so only the manufacturer’s confirmation counts.

4. What is actually inside counterfeit pens?

Regulators in the UK and Australia have found pens labeled Ozempic or Saxenda that contained insulin, which can cause dangerously low blood sugar. Other fakes have held unknown ingredients, the wrong strength, contaminated liquid, or nothing active. You cannot tell from the outside, which is why the source matters.

5. Who do I report a suspected fake to in India?

Report the product to your state drug controller (the state Food and Drugs Administration) and to CDSCO through cdsco.gov.in. Report any side effect to the Pharmacovigilance Programme of India or through the QR code displayed at your chemist. Keep the pen, carton, and bill for testing.

Medical Disclaimer
This article is for general education and is not a substitute for advice from a qualified doctor. GLP-1 medicines are prescription-only in India and should be used only under the supervision of a registered medical practitioner. If you think you have injected a counterfeit product and feel unwell, seek emergency medical care immediately.
  1. World Health Organization. Medical Product Alert N°2/2024: Falsified OZEMPIC (semaglutide). Geneva: WHO; 19 June 2024. https://www.who.int/news/item/19-06-2024-medical-product-alert-n-2-2024–falsified-ozempic-(semaglutide)
  2. Medicines and Healthcare products Regulatory Agency. Ozempic (semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products. Drug Safety Update. 2023;17(4):1. https://www.gov.uk/drug-safety-update/ozempicv-semaglutide-and-saxenda-liraglutide-vigilance-required-due-to-potentially-harmful-falsified-products
  3. Therapeutic Goods Administration. Counterfeit Ozempic pens detected and adverse event reported. Canberra: TGA, Australian Government. https://www.tga.gov.au/node/453016
  4. Ozawa S, Evans DR, Bessias S, Haynie DG, Yemeke TT, Laing SK, Herrington JE. Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis. JAMA Netw Open. 2018;1(4):e181662. doi:10.1001/jamanetworkopen.2018.1662. https://doi.org/10.1001/jamanetworkopen.2018.1662
Picture of Dr. Kaushal Patel

Dr. Kaushal Patel

MBBS, MD (Medicine), [Cardiologist Specialist in Diabetology & Obesity Management]